"Le CHU demande aux usagers de présenter à l’entrée de ses sites hospitaliers un « pass sanitaire », pour accéder au CHU. Ces consignes ne s’appliquent pas : - aux urgences adultes, pédiatriques, gynécoobstétriques, odontologiques et ophtalmologiques ; Plus d'infos sur le site internet du CHU"

During the past decade, CHU de Clermont Ferrand - Hôpital Gabriel-Montpied conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 6 trials, followed by "Assistance Publique - Hôpitaux de Paris" with 4 trials sponsored, "DatAids" with 2 trials sponsored, "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Fondation de Recherche sur l'Hypertension Artérielle" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied" are "Depressive Disorder, Major" (2 trials), "Fibromuscular Dysplasia" (2 trials), "Suicidal Ideation" (2 trials), "Venous Thromboembolism" (2 trials) and "ALS" (1 trials). Many other conditions were trialed in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied" in a lesser frequency.

Most popular intervention types in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied" are "Drug" (13 trials), "Biological" (8 trials), "Other" (7 trials), "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "1st perfusion of ketamine" (1 trials), "1st perfusion of saline" (1 trials), "2nd perfusion of ketamine" (1 trials) and "2nd perfusion of saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CHU de Clermont Ferrand - Hôpital Gabriel-Montpied". 1 are not yet recruiting, 13 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in CHU de Clermont Ferrand - Hôpital Gabriel-Montpied, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Clermont Ferrand - Hôpital Gabriel-Montpied, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".